CD274 and non-small cell lung carcinoma: Additionally, another study demonstrated a relationship between the BMI and ICI clinical efficacies in NSCLC,26 and BMI significantly correlated with ICI effectiveness in individuals with NSCLC who received second‐ or later‐line PD‐1/PD‐L1 blockade therapy.